An expert panel of the Central Drugs Standard Control Organisation on July 29 had recommended granting permission for conducting the study
11 Aug 2021 11:36 AM
ZyCoV-D showed safety and efficacy in a late-stage trial with more than 28,000 volunteers, including subjects in the 12-18 year age group
01 Jul 2021 9:06 AM
Human trials are scheduled to start across the country in July, developed and manufactured in Bharat Biotech’s facility in Hyderabad
30 Jun 2020 4:12 PM